Abstract 447: Preclinical development and characterization of IACS-16559, a dual bromodomain inhibitor of CBP/EP300, and its potential in AML subtypes
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Ciro Zanca, Michael Soth, Ajay Saw, Uttara Saran, Guang Gao, Jason Gay, Ningping Feng, Christopher Bristow, Joseph Marszalek, Kunal Rai, Virginia Giuliani, Tim Heffernan
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4409690754